肾上腺脑白质营养不良
家庭医学
病人登记处
医学
谱系学
遗传学
儿科
生物
内科学
历史
过氧化物酶体
受体
作者
Katsunobu Sakurai,Toya Ohashi,Nobuyuki Shimozawa,Joo-Hyun Seo,Torayuki Okuyama,Hiroyuki Ida
标识
DOI:10.1016/j.braindev.2018.07.007
摘要
Objective Early diagnosis is critical in achieving the best outcome following hematopoietic stem cell transplantation (HSCT) for X-linked adrenoleukodystrophy (X-ALD). We used a questionnaire to gather detailed clinical information and information regarding the anxieties of patients’ families using the registry system for X-ALD. Methods We and the patients’ families established the registry system for X-ALD in Japan. We created a questionnaire and distributed it to the patients’ families. Results Questionnaire data from 28 patients were collected. The median age at enrollment was 14.5 years. The most common type of X-ALD was the childhood cerebral form (22 patients, 78.6%). The median age at symptom onset was 7.4 years. Frequently reported initial observations were behavior or character changes (46.4%), gait disturbances (42.9%), strabismus (39.3%), reduced academic ability (32.1%), failing vision (21.4%), a positive family history (21.4%), clumsiness (17.9%), hearing disturbances (17.9%), convulsions (10.7%), and suspected psychiatric disorders (10.7%). The median duration from symptom onset to diagnosis was 12 months. The families of 12 patients (42.9%) with X-ALD who received HSCT were satisfied regardless of its effectiveness. Common concerns of patients’ families were worries regarding heritability of X-ALD (78.6%), present symptoms (57.1%), frequent hospital visits (42.9%), problems at school or work (42.9%), economic issues (35.7%), and limited information regarding X-ALD (32.1%). Conclusion This is the first study clarifying the clinical characteristics of X-ALD and the concerns of patients’ families using the registry system. Investigation of rare diseases using registry systems is very valuable for the understanding of such conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI